The ω‐conopeptide SNX‐111, an N‐type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischaemia
- 1 April 1994
- journal article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 150 (4), 459-461
- https://doi.org/10.1111/j.1748-1716.1994.tb09713.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia.Proceedings of the National Academy of Sciences, 1993
- Chapter 8 Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemiaPublished by Elsevier ,1993
- Pathophysiology and treatment of focal cerebral ischemiaJournal of Neurosurgery, 1992
- Pathophysiology and treatment of focal cerebral ischemiaJournal of Neurosurgery, 1992
- Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the ratExperimental Brain Research, 1992
- The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal DeathAnnual Review of Neuroscience, 1990
- Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke, 1986
- Peptide Neurotoxins from Fish-Hunting Cone SnailsScience, 1985